Role of epidermal growth factor receptor in vascular structure and function
PURPOSE OF THE REVIEWThe epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase with a wide implication in tumor biology, wound healing and development. Besides acting as a growth factor receptor activated by ligands such as EGF, the EGFR can also be transactivated and thereby mediate...
Gespeichert in:
Veröffentlicht in: | Current opinion in nephrology and hypertension 2014-03, Vol.23 (2), p.113-121 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 121 |
---|---|
container_issue | 2 |
container_start_page | 113 |
container_title | Current opinion in nephrology and hypertension |
container_volume | 23 |
creator | Schreier, Barbara Gekle, Michael Grossmann, Claudia |
description | PURPOSE OF THE REVIEWThe epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase with a wide implication in tumor biology, wound healing and development. Besides acting as a growth factor receptor activated by ligands such as EGF, the EGFR can also be transactivated and thereby mediate cross-talk with different signaling pathways. The aim of this review is to illustrate the Janus-faced function of the EGFR in the vasculature with its relevance for vascular biology and disease.
RECENT FINDINGSOver recent years, the number of identified signaling partners of the EGFR has steadily increased, as have the biological processes in which the EGFR is thought to be involved. Recently, new models have allowed investigation of EGFR effects in vivo, shedding some light on the overall function of the EGFR in the vasculature. At the same time, EGFR inhibitors and antibodies have become increasingly established in cancer therapy, providing potential therapeutic tools for decreasing EGFR signaling.
SUMMARYThe EGFR is a versatile signaling pathway integrator associated with vascular homeostasis and disease. In addition to modulating basal vascular tone and tissue homeostasis, the EGFR also seems to be involved in proinflammatory, proliferative, migratory and remodeling processes, with enhanced deposition of extracellular matrix components, thereby promoting vascular diseases such as hypertension or atherosclerosis. |
doi_str_mv | 10.1097/01.mnh.0000441152.62943.29 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1499119635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1499119635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4409-516cc78c3487189b1cdced3cc7d8e3d9a95d3e079215113515d8b01cbaf31fd73</originalsourceid><addsrcrecordid>eNqNkFGL1DAQx4OcuHurX0GCT_fSmmnSNvFBkEM9cUEQfQ5pMrXVtNlLWhe_vVl3PV-dlxmG38wffoS8AFYCU-1LBuU0DyXLJQRAXZVNpQQvK_WIbEG0vGhqwa_yzJqqELKCDblO6XvmuQDxhGwqIRi0Um7Jx8_BIw09xcPoME7G028xHJeB9sYuIdKIFg-nYZzpT5Ps6k2kaYmrXdaI1MyO9utslzHMT8nj3viEzy59R76-e_vl9q7Yf3r_4fbNvrA5VhU1NNa20nIhW5CqA-ssOp53TiJ3yqjacWStqqAG4DXUTnYMbGd6Dr1r-Y7cnP8eYrhfMS16GpNF782MYU0ahFIAquF1Rl-dURtDShF7fYjjZOIvDUyfZGoGOsvU_2TqPzJ1pfLx80vO2k3oHk7_2svA6zNwDH7BmH749YhRD2j8MvxPwm_DHYTD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1499119635</pqid></control><display><type>article</type><title>Role of epidermal growth factor receptor in vascular structure and function</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Schreier, Barbara ; Gekle, Michael ; Grossmann, Claudia</creator><creatorcontrib>Schreier, Barbara ; Gekle, Michael ; Grossmann, Claudia</creatorcontrib><description>PURPOSE OF THE REVIEWThe epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase with a wide implication in tumor biology, wound healing and development. Besides acting as a growth factor receptor activated by ligands such as EGF, the EGFR can also be transactivated and thereby mediate cross-talk with different signaling pathways. The aim of this review is to illustrate the Janus-faced function of the EGFR in the vasculature with its relevance for vascular biology and disease.
RECENT FINDINGSOver recent years, the number of identified signaling partners of the EGFR has steadily increased, as have the biological processes in which the EGFR is thought to be involved. Recently, new models have allowed investigation of EGFR effects in vivo, shedding some light on the overall function of the EGFR in the vasculature. At the same time, EGFR inhibitors and antibodies have become increasingly established in cancer therapy, providing potential therapeutic tools for decreasing EGFR signaling.
SUMMARYThe EGFR is a versatile signaling pathway integrator associated with vascular homeostasis and disease. In addition to modulating basal vascular tone and tissue homeostasis, the EGFR also seems to be involved in proinflammatory, proliferative, migratory and remodeling processes, with enhanced deposition of extracellular matrix components, thereby promoting vascular diseases such as hypertension or atherosclerosis.</description><identifier>ISSN: 1062-4821</identifier><identifier>EISSN: 1473-6543</identifier><identifier>DOI: 10.1097/01.mnh.0000441152.62943.29</identifier><identifier>PMID: 24401788</identifier><language>eng</language><publisher>England: Wolters Kluwer Health | Lippincott Williams & Wilkins</publisher><subject>Animals ; Antibodies - therapeutic use ; Antineoplastic Agents - therapeutic use ; Blood Vessels - drug effects ; Blood Vessels - enzymology ; Blood Vessels - pathology ; Blood Vessels - physiopathology ; Endothelial Cells - enzymology ; Humans ; Ligands ; Muscle, Smooth, Vascular - enzymology ; Myocytes, Smooth Muscle - enzymology ; Protein Kinase Inhibitors - therapeutic use ; Receptor Cross-Talk ; Receptor, Epidermal Growth Factor - antagonists & inhibitors ; Receptor, Epidermal Growth Factor - metabolism ; Signal Transduction - drug effects ; Vascular Diseases - drug therapy ; Vascular Diseases - enzymology</subject><ispartof>Current opinion in nephrology and hypertension, 2014-03, Vol.23 (2), p.113-121</ispartof><rights>2014 Wolters Kluwer Health | Lippincott Williams & Wilkins</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4409-516cc78c3487189b1cdced3cc7d8e3d9a95d3e079215113515d8b01cbaf31fd73</citedby><cites>FETCH-LOGICAL-c4409-516cc78c3487189b1cdced3cc7d8e3d9a95d3e079215113515d8b01cbaf31fd73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24401788$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schreier, Barbara</creatorcontrib><creatorcontrib>Gekle, Michael</creatorcontrib><creatorcontrib>Grossmann, Claudia</creatorcontrib><title>Role of epidermal growth factor receptor in vascular structure and function</title><title>Current opinion in nephrology and hypertension</title><addtitle>Curr Opin Nephrol Hypertens</addtitle><description>PURPOSE OF THE REVIEWThe epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase with a wide implication in tumor biology, wound healing and development. Besides acting as a growth factor receptor activated by ligands such as EGF, the EGFR can also be transactivated and thereby mediate cross-talk with different signaling pathways. The aim of this review is to illustrate the Janus-faced function of the EGFR in the vasculature with its relevance for vascular biology and disease.
RECENT FINDINGSOver recent years, the number of identified signaling partners of the EGFR has steadily increased, as have the biological processes in which the EGFR is thought to be involved. Recently, new models have allowed investigation of EGFR effects in vivo, shedding some light on the overall function of the EGFR in the vasculature. At the same time, EGFR inhibitors and antibodies have become increasingly established in cancer therapy, providing potential therapeutic tools for decreasing EGFR signaling.
SUMMARYThe EGFR is a versatile signaling pathway integrator associated with vascular homeostasis and disease. In addition to modulating basal vascular tone and tissue homeostasis, the EGFR also seems to be involved in proinflammatory, proliferative, migratory and remodeling processes, with enhanced deposition of extracellular matrix components, thereby promoting vascular diseases such as hypertension or atherosclerosis.</description><subject>Animals</subject><subject>Antibodies - therapeutic use</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Blood Vessels - drug effects</subject><subject>Blood Vessels - enzymology</subject><subject>Blood Vessels - pathology</subject><subject>Blood Vessels - physiopathology</subject><subject>Endothelial Cells - enzymology</subject><subject>Humans</subject><subject>Ligands</subject><subject>Muscle, Smooth, Vascular - enzymology</subject><subject>Myocytes, Smooth Muscle - enzymology</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Receptor Cross-Talk</subject><subject>Receptor, Epidermal Growth Factor - antagonists & inhibitors</subject><subject>Receptor, Epidermal Growth Factor - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Vascular Diseases - drug therapy</subject><subject>Vascular Diseases - enzymology</subject><issn>1062-4821</issn><issn>1473-6543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkFGL1DAQx4OcuHurX0GCT_fSmmnSNvFBkEM9cUEQfQ5pMrXVtNlLWhe_vVl3PV-dlxmG38wffoS8AFYCU-1LBuU0DyXLJQRAXZVNpQQvK_WIbEG0vGhqwa_yzJqqELKCDblO6XvmuQDxhGwqIRi0Um7Jx8_BIw09xcPoME7G028xHJeB9sYuIdKIFg-nYZzpT5Ps6k2kaYmrXdaI1MyO9utslzHMT8nj3viEzy59R76-e_vl9q7Yf3r_4fbNvrA5VhU1NNa20nIhW5CqA-ssOp53TiJ3yqjacWStqqAG4DXUTnYMbGd6Dr1r-Y7cnP8eYrhfMS16GpNF782MYU0ahFIAquF1Rl-dURtDShF7fYjjZOIvDUyfZGoGOsvU_2TqPzJ1pfLx80vO2k3oHk7_2svA6zNwDH7BmH749YhRD2j8MvxPwm_DHYTD</recordid><startdate>201403</startdate><enddate>201403</enddate><creator>Schreier, Barbara</creator><creator>Gekle, Michael</creator><creator>Grossmann, Claudia</creator><general>Wolters Kluwer Health | Lippincott Williams & Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201403</creationdate><title>Role of epidermal growth factor receptor in vascular structure and function</title><author>Schreier, Barbara ; Gekle, Michael ; Grossmann, Claudia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4409-516cc78c3487189b1cdced3cc7d8e3d9a95d3e079215113515d8b01cbaf31fd73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Antibodies - therapeutic use</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Blood Vessels - drug effects</topic><topic>Blood Vessels - enzymology</topic><topic>Blood Vessels - pathology</topic><topic>Blood Vessels - physiopathology</topic><topic>Endothelial Cells - enzymology</topic><topic>Humans</topic><topic>Ligands</topic><topic>Muscle, Smooth, Vascular - enzymology</topic><topic>Myocytes, Smooth Muscle - enzymology</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Receptor Cross-Talk</topic><topic>Receptor, Epidermal Growth Factor - antagonists & inhibitors</topic><topic>Receptor, Epidermal Growth Factor - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Vascular Diseases - drug therapy</topic><topic>Vascular Diseases - enzymology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schreier, Barbara</creatorcontrib><creatorcontrib>Gekle, Michael</creatorcontrib><creatorcontrib>Grossmann, Claudia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in nephrology and hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schreier, Barbara</au><au>Gekle, Michael</au><au>Grossmann, Claudia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of epidermal growth factor receptor in vascular structure and function</atitle><jtitle>Current opinion in nephrology and hypertension</jtitle><addtitle>Curr Opin Nephrol Hypertens</addtitle><date>2014-03</date><risdate>2014</risdate><volume>23</volume><issue>2</issue><spage>113</spage><epage>121</epage><pages>113-121</pages><issn>1062-4821</issn><eissn>1473-6543</eissn><abstract>PURPOSE OF THE REVIEWThe epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase with a wide implication in tumor biology, wound healing and development. Besides acting as a growth factor receptor activated by ligands such as EGF, the EGFR can also be transactivated and thereby mediate cross-talk with different signaling pathways. The aim of this review is to illustrate the Janus-faced function of the EGFR in the vasculature with its relevance for vascular biology and disease.
RECENT FINDINGSOver recent years, the number of identified signaling partners of the EGFR has steadily increased, as have the biological processes in which the EGFR is thought to be involved. Recently, new models have allowed investigation of EGFR effects in vivo, shedding some light on the overall function of the EGFR in the vasculature. At the same time, EGFR inhibitors and antibodies have become increasingly established in cancer therapy, providing potential therapeutic tools for decreasing EGFR signaling.
SUMMARYThe EGFR is a versatile signaling pathway integrator associated with vascular homeostasis and disease. In addition to modulating basal vascular tone and tissue homeostasis, the EGFR also seems to be involved in proinflammatory, proliferative, migratory and remodeling processes, with enhanced deposition of extracellular matrix components, thereby promoting vascular diseases such as hypertension or atherosclerosis.</abstract><cop>England</cop><pub>Wolters Kluwer Health | Lippincott Williams & Wilkins</pub><pmid>24401788</pmid><doi>10.1097/01.mnh.0000441152.62943.29</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1062-4821 |
ispartof | Current opinion in nephrology and hypertension, 2014-03, Vol.23 (2), p.113-121 |
issn | 1062-4821 1473-6543 |
language | eng |
recordid | cdi_proquest_miscellaneous_1499119635 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Animals Antibodies - therapeutic use Antineoplastic Agents - therapeutic use Blood Vessels - drug effects Blood Vessels - enzymology Blood Vessels - pathology Blood Vessels - physiopathology Endothelial Cells - enzymology Humans Ligands Muscle, Smooth, Vascular - enzymology Myocytes, Smooth Muscle - enzymology Protein Kinase Inhibitors - therapeutic use Receptor Cross-Talk Receptor, Epidermal Growth Factor - antagonists & inhibitors Receptor, Epidermal Growth Factor - metabolism Signal Transduction - drug effects Vascular Diseases - drug therapy Vascular Diseases - enzymology |
title | Role of epidermal growth factor receptor in vascular structure and function |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T00%3A31%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20epidermal%20growth%20factor%20receptor%20in%20vascular%20structure%20and%20function&rft.jtitle=Current%20opinion%20in%20nephrology%20and%20hypertension&rft.au=Schreier,%20Barbara&rft.date=2014-03&rft.volume=23&rft.issue=2&rft.spage=113&rft.epage=121&rft.pages=113-121&rft.issn=1062-4821&rft.eissn=1473-6543&rft_id=info:doi/10.1097/01.mnh.0000441152.62943.29&rft_dat=%3Cproquest_cross%3E1499119635%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1499119635&rft_id=info:pmid/24401788&rfr_iscdi=true |